{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:20Z","timestamp":1786991240290,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaci.2021.01.025","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T14:58:15Z","timestamp":1612882695000},"page":"2249-2262.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Using data from food challenges to inform management of consumers with food allergy: A\u00a0systematic review with individual participant data meta-analysis"],"prefix":"10.1016","volume":"147","author":[{"given":"Nandinee","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Anagnostou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Marty","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Sharon","family":"Chinthrajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.N. Clare","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Purington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Remington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh A.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross A.R.","family":"Yarham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.01.025_bib1","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jaci.2017.01.030","article-title":"Peanut Allergen Threshold Study (PATS): novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy","volume":"139","author":"Hourihane","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/pai.13244","article-title":"Can my child with IgE-mediated peanut allergy introduce foods labeled with \"may contain traces\"?","volume":"31","author":"Graham","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fct.2013.10.032","article-title":"Establishment of reference doses for residues of allergenic foods: report of the VITAL Expert Panel","volume":"63","author":"Taylor","year":"2014","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaci.2021.01.025_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111259","article-title":"Updated population minimal eliciting dose distributions for use in risk assessment of 14 priority food allergens","volume":"139","author":"Remington","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaci.2021.01.025_bib5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2014.10.047","article-title":"How much is too much? Threshold dose distributions for 5 food allergens","volume":"135","author":"Ballmer-Weber","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib6","doi-asserted-by":"crossref","first-page":"d6180","DOI":"10.1136\/bmj.d6180","article-title":"Advisory food labels: consumers with allergies need more than \"traces\" of information","volume":"343","author":"Turner","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2021.01.025_bib7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/all.12614","article-title":"Precautionary allergen labelling: perspectives from key stakeholder groups","volume":"70","author":"DunnGalvin","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104751","article-title":"Can we define a level of protection for allergic consumers that everyone can accept?","volume":"117","author":"Madsen","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jaci.2021.01.025_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2222.2011.03868.x","article-title":"Can we define a tolerable level of risk in food allergy? Report from a EuroPrevall\/UK Food Standards Agency workshop","volume":"42","author":"Madsen","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/all.12924","article-title":"Can we identify patients at risk of life-threatening allergic reactions to food?","volume":"71","author":"Turner","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2021.01.025_bib12","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2012.10.017","article-title":"Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report","volume":"130","author":"Sampson","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.fct.2009.12.013","article-title":"Threshold dose for peanut: risk characterization based upon diagnostic oral challenge of a series of 286 peanut-allergic individuals","volume":"48","author":"Taylor","year":"2010","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaci.2021.01.025_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaci.2012.10.034","article-title":"Threshold dose distributions for 5 major allergenic foods in children","volume":"131","author":"Blom","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/pai.12107","article-title":"Can we predict severe reactions during peanut challenges in children?","volume":"24","author":"van Erp","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1542\/peds.111.S3.1601","article-title":"Anaphylaxis and emergency treatment","volume":"111","author":"Sampson","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2021.01.025_bib17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.01.025_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/cea.12558","article-title":"Objective eliciting doses of peanut-allergic adults and children can be combined for risk assessment purposes","volume":"45","author":"Klemans","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib20","article-title":"World Allergy Organisation Anaphylaxis Committee. Anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"WAO Journal"},{"key":"10.1016\/j.jaci.2021.01.025_bib21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/all.12671","article-title":"Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study","volume":"70","author":"Kukkonen","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2222.2005.02312.x","article-title":"Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community?","volume":"35","author":"Hourihane","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib23","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2015.04.029","article-title":"Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy","volume":"136","author":"Wang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib24","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaip.2017.09.016","article-title":"ARC001 Study Group. Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial","volume":"6","author":"Bird","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.01.025_bib25","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1001\/jama.2017.16591","article-title":"Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: a randomized clinical trial","volume":"318","author":"Sampson","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2021.01.025_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/cea.13078","article-title":"Predicting reactivity threshold in children with anaphylaxis to peanut","volume":"48","author":"Reier-Nilsen","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib27","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.3389\/fimmu.2018.02057","article-title":"Eliciting dose and safety outcomes from a large dataset of standardized multiple food challenges","volume":"9","author":"Purington","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib28","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.01.025_bib29","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jama.2019.1113","article-title":"Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial","volume":"321","author":"Fleischer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2021.01.025_bib30","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaci.2019.06.038","article-title":"Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy:\u00a0a randomized controlled study","volume":"144","author":"Dua","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib31","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/all.13442","article-title":"Low frequency of soya allergy in peanut-allergic children: relevance to allergen labelling on medicines","volume":"73","author":"Patel","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib32","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.01.025_bib33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2352-4642(20)30234-0","article-title":"Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"4","author":"O'B Hourihane","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaci.2021.01.025_bib35","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1002\/hsr2.178","article-title":"Arcsine-based transformations for meta-analysis of proportions: pros, cons, and alternatives","volume":"3","author":"Lin","year":"2020","journal-title":"Health Science Reports"},{"key":"10.1016\/j.jaci.2021.01.025_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jrsm.1348","article-title":"Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions","volume":"10","author":"Schwarzer","year":"2019","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jaci.2021.01.025_bib37","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jaci.2019.07.046","article-title":"Deriving individual threshold doses from clinical food challenge data for population risk assessment of food allergens","volume":"144","author":"Westerhout","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib38","doi-asserted-by":"crossref","first-page":"111831","DOI":"10.1016\/j.fct.2020.111831","article-title":"Full range of population eliciting dose values for 14 priority allergenic foods and recommendations for use in risk characterization","volume":"146","author":"Houben","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaci.2021.01.025_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1939-4551-7-10","article-title":"Precautionary labelling of foods for allergen content: are we ready for a global framework?","volume":"7","author":"Allen","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2021.01.025_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.fct.2019.01.025","article-title":"Sensitivity analysis to derive a food consumption point estimate for deterministic food allergy risk assessment","volume":"125","author":"Blom","year":"2019","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaci.2021.01.025_bib41","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/cea.13464","article-title":"Evidence-based approaches to the application of precautionary allergen labelling: report from two iFAAM workshops","volume":"49","author":"DunnGalvin","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jaci.2020.03.035","article-title":"Biomarkers of severity and threshold of allergic reactions during oral peanut challenges","volume":"146","author":"Santos","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1398-9995.2012.02838.x","article-title":"Outcome of oral food challenges in children in relation to symptom-eliciting allergen dose and allergen-specific IgE","volume":"67","author":"Rolinck-Werninghaus","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib44","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/all.13423","article-title":"Prediction of the severity of allergic reactions to foods","volume":"73","author":"Pettersson","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/all.12997","article-title":"Crossing the threshold: can outcome data from food challenges be used to predict risk of anaphylaxis in the community?","volume":"72","author":"Turner","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib46","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/all.13405","article-title":"How does dose impact on the severity of food-induced allergic reactions, and can this improve risk assessment for allergenic foods? Report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop","volume":"73","author":"Dubois","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.025_bib47","doi-asserted-by":"crossref","unstructured":"Turner PJ, d\u2019Art YM, Duca B, Chastell SA, Marco-Martin G, Vera-Berrios RN, et\u00a0al. Single dose oral challenges to validate eliciting doses in children with cow\u2019s milk allergy [e-pub ahead of print]. Paediatr Allergy Immunol https:\/\/doi.org\/10.22541\/au.160221621.11001222\/v1, Accessed November 26, 2020.","DOI":"10.22541\/au.160221621.11001222\/v1"},{"key":"10.1016\/j.jaci.2021.01.025_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaci.2013.06.042","article-title":"Allergen reference doses for precautionary labeling (VITAL 2.0): clinical implications","volume":"133","author":"Allen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.025_bib49","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaci.2014.03.035","article-title":"Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy","volume":"134","author":"Blumchen","year":"2014","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492100172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492100172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:30:21Z","timestamp":1758792621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492100172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S009167492100172X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.01.025","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739535753.793585395","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using data from food challenges to inform management of consumers with food allergy: A\u00a0systematic review with individual participant data meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}